创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

维甲酸相关孤儿受体γt小分子抑制剂的研究进展

Research Progress of Small Molecule Inhibitors of Retinoic Acid-Related Orphan Receptor γt

  • 摘要: 维甲酸相关孤儿受体γt (retinoic acid-related orphan receptor γt,RORγt)属于核受体家族,因其没有可识别的天然配体,被称为孤儿核受体。研究表明,RORγt通过调节辅助T细胞17(T helper cell 17,Th 17)的分化和多种细胞因子的表达,在炎症和自身免疫性疾病的发生发展中发挥重要作用。RORγt抑制剂包括拮抗剂和反向激动剂,可以抑制炎症和自身免疫性疾病的发生发展。通过对RORγt的结构、功能以及在Th17调节的相关炎症和自身免疫性疾病中的作用进行概述,并且综述了近年来小分子RORγt抑制剂的开发、临床应用及面临的挑战,以期为RORγt小分子抑制剂的研发提供参考。

     

    Abstract: Retinoic acid-related orphan receptor γt (RORγt), a member of the nuclear receptor family, is known as orphan nuclear receptor due to absence of recognizable natural ligands. Studies have shown that RORγt plays a significant role in the occurrence and development of inflammation and autoimmune diseases by regulating the differentiation of helper T cells 17 (Th17) and the expression of various cytokines. RORγt inhibitors, including antagonists and inverse agonists, can suppress the development of inflammation and autoimmune diseases. This review summarizes the structure and function of RORγt and its role in related inflammation and autoimmune diseases regulated by Th17, and provides a comprehensive overview of the development, clinical application and challenges of small molecule RORγt inhibitors in recent years, in order to offer some valuable insights for the development of small molecule RORγt inhibitors.

     

/

返回文章
返回